Company intelligence / Profile preview

WellCode.Life

Warsaw, Poland

Ownership: Private
Employees: ~25
Development stage: Other

Overview

WellCode is a personalized health and longevity company that utilizes genetic testing and epigenetic analysis to provide tailored wellness recommendations. The company offers a comprehensive platform that integrates DNA data with blood biomarkers and lifestyle metrics to generate actionable insights for optimizing metabolic health and slowing the aging process. Their services include personalized nutrition plans, supplement recommendations, and biological age tracking. WellCode aims to empower individuals with data-driven strategies to improve their healthspan and prevent chronic diseases through proactive, individualized care.

Therapeutic areas: OtherMetabolic Disorders
Modalities: NutraceuticalsLifestyle Intervention
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on WellCode.Life.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WellCode.Life.

Explore the full profile